Consano Bio Receives FDA Fast Track Designation for C-1101 in Chronic, Painful Lumbosacral Radiculopathy (LSR) or Chronic Sciatica

RegulatoryC-1101Positive

AI Analysis

Summary

Consano Bio received FDA Fast Track Designation for C-1101, an investigational non-opioid biologic for chronic sciatica, following IND application clearance.

Outcome Details

FDA Fast Track Designation granted; IND application cleared

Importance:7/10

Sentiment:

0.80

FDA Fast TrackIND clearancenon-opioid biologicchronic painregulatory milestone

Read the original article

Published by PR Newswire Biotech on August 18, 2026 12:10 PM

Read Original